Due to successful results in the first phase of our study on the effects of our Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project.
Testing our products to prove clinical efficacy is one of our core values, and something that sets us apart in the industry. Due to successful results in the first phase of our study on the effects of our Lycored Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project. The results of the study showed that subjects who ingested our blend had significantly reduced systolic and diastolic blood pressures and increased retinal capillary blood flow markers. Professor Alon Harris, principal clinical study investigator, believes that “these initial results of the […] study showcase the importance of the development of supplements for eyes and where the future of the vision health industry is heading.” We hope to keep the promising results coming, and we’re excited to see what phase two brings.
Lumenato’s EFSA approval The European Food Safety Authority (EFSA) Panel on Nutrition, Novel Foods, and Food Allergens has issued a positive scientific opinion on Lumenato™, affirming its safety as a...
Lycored, a global leader in naturally derived carotenoids, is celebrating its 30th anniversary with a vibrant innovation: the launch of three superstable, nature-based color emulsions. Introduced at the IFT FIRST...
Interested in speaking directly with a member of our team?
Click below to get in touch.